ALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)

Basit Öğe Kaydı
dc.contributor.authorSolomon, B. J.
dc.contributor.authorWu, Y-L.
dc.contributor.authorDziadziuszko, R.
dc.contributor.authorBarlesi, F.
dc.contributor.authorNishio, M.
dc.contributor.authorAhn, J. S.
dc.contributor.authorHorinouchi, H.
dc.date.accessioned2026-04-04T13:35:13Z
dc.date.available2026-04-04T13:35:13Z
dc.date.issued2024
dc.departmentİnönü Üniversitesi
dc.descriptionAnnual Congress of the European-Society-for-Medical-Oncology (ESMO) -- SEP 13-17, 2024 -- Barcelona, SPAIN
dc.description.abstract[No abstract available]
dc.description.sponsorshipF. Hoffmann-La Roche Ltd.
dc.description.sponsorshipF. Hoffmann-La Roche Ltd.
dc.description.sponsorshipEuropean Soc Med Oncol
dc.identifier.doi10.1016/j.annonc.2024.08.1265
dc.identifier.endpageS775
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.startpageS775
dc.identifier.urihttps://doi.org/10.1016/j.annonc.2024.08.1265
dc.identifier.urihttps://hdl.handle.net/11616/109700
dc.identifier.volume35
dc.identifier.wosWOS:001326612901509
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250329
dc.titleALINA: Exploratory biomarker analyses in patients (pts) with resected ALK plus non-small cell lung cancer (NSCLC) treated with adjuvant alectinib vs chemotherapy (chemo)
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu